Show simple item record

dc.contributor.authorLord, Rianne M.*
dc.contributor.authorAllison, Simon J.*
dc.contributor.authorRafferty, K.*
dc.contributor.authorGhandhi, L.*
dc.contributor.authorPask, C.M.*
dc.contributor.authorMcGowan, P.C.*
dc.date.accessioned2016-09-28T11:00:17Z
dc.date.available2016-09-28T11:00:17Z
dc.date.issued2016-09-07
dc.identifier.citationLord RM, Allison SJ, Rafferty K, Ghandi L, Pask CM and McGowan PC (2016) Cytotoxic hydrogen bridged ruthenium quinaldamide complexes showing induced cancer cell death by apoptosis. Dalton Transactions. 45: 13196-13203.en_US
dc.identifier.urihttp://hdl.handle.net/10454/9487
dc.descriptionyesen_US
dc.description.abstractThis report presents the first known p-cymene ruthenium quinaldamide complexes which are stabilised by a hydrogen-bridging atom, [{(p-cym)RuIIX(N,N)}{H+}{(N,N)XRuII(p-cym)}][PF6] (N,N = functionalised quinaldamide and X = Cl or Br). These complexes are formed by a reaction of [p-cymRu(μ-X)2]2 with a functionalised quinaldamide ligand. When filtered over NH4PF6, and under aerobic conditions the equilibrium of NH4PF6 ⇔ NH3 + HPF6 enables incorporation of HPF6 and the stabilisation of two monomeric ruthenium complexes by a bridging H+, which are counter-balanced by a PF6 counterion. X-ray crystallographic analysis is presented for six new structures with O⋯O distances of 2.420(4)–2.448(15) Å, which is significant for strong hydrogen bonds. Chemosensitivity studies against HCT116, A2780 and cisplatinresistant A2780cis human cancer cells showed the ruthenium complexes with a bromide ancillary ligand to be more potent than those with a chloride ligand. The 4’-fluoro compounds show a reduction in potency for both chloride and bromide complexes against all cell lines, but an increase in selectivity towards cancer cells compared to non-cancer ARPE-19 cells, with a selectivity index >1. Mechanistic studies showed a clear correlation between IC50 values and induction of cell death by apoptosisen_US
dc.language.isoenen_US
dc.rights© 2016 RSC. Reproduced with permission from the publisher in accordance with the publisher's self-archiving policy.
dc.subjectp-cymene ruthenium quinaldamide complexes; Hydrogen bridged; Chemotherapy; Anti-cancer agentsen_US
dc.titleCytotoxic hydrogen bridged ruthenium quinaldamide complexes showing induced cancer cell death by apoptosisen_US
dc.status.refereedyesen_US
dc.date.Accepted2016-07-01
dc.date.application2016-07-01
dc.typeArticleen_US
dc.type.versionAccepted manuscripten_US
dc.identifier.doihttps://doi.org/10.1039/c6dt01464j
refterms.dateFOA2018-07-25T14:31:59Z


Item file(s)

Thumbnail
Name:
Accepted Dalton Trans_Ru picol ...
Size:
875.0Kb
Format:
PDF
Description:
Keep suppressed - published version
Thumbnail
Name:
Lord_Dalton Trans_MS_accepted.pdf
Size:
795.1Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record